| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenue | 1,076 | 1,348 | 2,739 | 46,333 |
| Cost of goods sold | -58 | 85 | 252 | 5,295 |
| Research and development | 1,209 | 5,865 | 9,175 | 21,708 |
| Selling, general and administrative | 5,295 | 7,057 | 8,106 | 17,554 |
| Restructuring charge | 41 | 393 | 126 | 18,554 |
| Total operating costs and expenses | 6,487 | 13,400 | 17,659 | 63,111 |
| Loss from operations | -5,411 | -12,052 | -14,920 | -16,778 |
| Interest expense | 2,083 | 2,009 | 2,257 | 4,994 |
| Loss on debt extinguishments | -6,583 | NaN | NaN | NaN |
| Interest income and other income (expenses), net | 931 | 286 | 413 | 3,802 |
| Total interest and other, net | -7,735 | -1,723 | -1,844 | -1,192 |
| Loss from continuing operations before income taxes | -13,146 | -13,775 | -16,764 | -17,970 |
| Investment income (loss) | NaN | NaN | NaN | 898 |
| Provision for (benefit from) income taxes | 0 | -92 | 2 | 12 |
| Loss from continuing operations | -13,146 | -13,683 | -16,766 | NaN |
| Product revenue, net | 167,179 | NaN | NaN | NaN |
| Cost of goods sold | 3,761 | NaN | NaN | NaN |
| Research and development | 438 | NaN | NaN | NaN |
| Selling, general and administrative | 1,311 | NaN | NaN | NaN |
| Total operating costs and expenses | 5,510 | NaN | NaN | NaN |
| Income from operations | 161,669 | NaN | NaN | NaN |
| Interest expense | 1,900 | NaN | NaN | NaN |
| Gain on divestiture | 52,163 | NaN | NaN | NaN |
| Interest income and other income (expenses), net | -475 | NaN | NaN | NaN |
| Total interest and other, net | -50,738 | NaN | NaN | NaN |
| Income before income taxes | 212,407 | NaN | NaN | NaN |
| Provision for income taxes | 0 | NaN | NaN | NaN |
| Investment income in unconsolidated variable interest entity | -1,375 | NaN | NaN | NaN |
| Income from discontinued operations, net of tax | 213,782 | 6,080 | 21,405 | NaN |
| Net income (loss) | 200,636 | -7,603 | 4,639 | -17,084 |
| Basic EPS | 49.61 | -1.88 | 0.05 | -0.17 |
| Diluted EPS | 49.61 | -1.88 | 0.05 | -0.17 |
| Basic Average Shares | 4,044,000 | 4,042,000 | 100,954,000 | 100,515,000 |
| Diluted Average Shares | 4,044,000 | 4,042,000 | 100,954,000 | 100,515,000 |
FIBROGEN INC (FGEN)
FIBROGEN INC (FGEN)